Clay Siegall’s Passion Against Cancer

Seattle Genetics was founded by Dr. Clay Siegall in 1998. It is a biotech company with specialization in the manufacturing of therapy formulated drugs that are intended for diseases that have not had significant improvements in mortality rates for the past decades.

After having established Seattle Genetic, Dr. Siegall was able to lead the company in becoming well-known within the therapy sector by developing an FDA-approved drug conjugate for antibodies, which is a first of its kind that now has numerous approved indications. Seattle was also able to create a full-bodied pipeline of over twenty drugs and managed to foster working partnerships with drug manufacturers such as Pfizer, Genentech, Bayer, to name a few.

With the management of Dr. Siegall, Seattle Genetics became a power player in the cancer research industry. He has many big visions for the company that includes a growing list of drugs that are in the development stage of the pipeline and an expanding number of impending indications intended for the drug portfolio of the company.

Dr. Siegall is confident that cancer treatments like chemotherapy are a thing of the past, and that the drugs being created and manufactured by Seattle are better since they are more tolerable and more efficient in targeting the disease.

In an interview with Dr. Clay Siegall, he said he became interested in cancer treatment because while he was studying medicine in the University of Maryland, a family member got sick of cancer, and he witness the brutality of the procedure that was available. He further commented that the family member almost died of anemia because of the treatment involved and not because of the presence of cancer.

Next, he said that hard work is very essential in becoming successful because in truth everybody did not differ greatly in intellect but significantly differed in work habits. He added that working passionately and being focused are the certain ingredients for success. IQ, where you were schooled, and people you may know are just secondary factors.

Dr. Siegall has a degree in Zoology from the University of Maryland and earned his Ph.D. in Genetics from the University of George Washington.

Leave a Reply

Your email address will not be published. Required fields are marked *